Table 3. Challenges in keeping HIV-positive pregnant women in care [69].

• Women initiated on lifelong ARVs during pregnancy were five times more likely than women who started ARVs in WHO stage 3/4 or with a CD4 cell count of 350 cells/ml or less to never return after their initial clinic visit.

• Women initiating lifelong ARVs while breastfeeding were twice as likely to miss their first follow-up visit.

• Loss to follow-up was highest in pregnant women who began lifelong ARVs at large clinics on the day they were diagnosed with HIV.